ACPA: Erster serologischer Marker für die Wegenersche Granulomatose.

Translated title of the contribution: ACPA: the first serologic marker for Wegener's granulomatosis

A. Beigel*, W. L. Gross

*Corresponding author for this work
1 Citation (Scopus)


The anticytoplasmatic autoantibody against intracytoplasmatic antigens of granulocytes (ACPA) was demonstratable in 23 patients in the active generalised or incomplete remission phase of Wegener's granulomatosis, but absent in 17 patients in the initial or complete remission phase. The test was negative in 900 serum samples from a control group. This autoantibody seems to be a marker of unusual specificity for Wegener's granuloma, and contributes to better assessment of activity in this disease.

Translated title of the contributionACPA: the first serologic marker for Wegener's granulomatosis
Original languageGerman
Issue number9
Pages (from-to)390-392
Number of pages3
Publication statusPublished - 09.1987

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)


Dive into the research topics of 'ACPA: the first serologic marker for Wegener's granulomatosis'. Together they form a unique fingerprint.

Cite this